Skip to main content
AMCP 2025 Main banner
Back

Focus on Managed Care Pharmacy

(M2) Employer Perspectives on High-Impact Drugs

Tuesday, April 1, 2025
1:30 PM – 2:45 PM CST
Location: Grandballroom C
ACPE UAN:N/A | Contact Hours: N/A | Activity Type: N/A
Please note this session is not accredited for continuing pharmacy education.

As high-investment drugs continue to reshape the healthcare landscape, employers and purchasers of insurance play a critical role in evaluating their value and impact. This session will explore their perspectives on cost, coverage, and clinical outcomes. Attendees will gain insight into emerging high-impact drug classes, evolving trends in pharmacy benefit management, and strategies employers use to assess drug affordability. By understanding these viewpoints, managed care pharmacists can better align strategies to support sustainable access, value-driven solutions, and optimized outcomes for high-impact therapies.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Recognize emerging high-impact drug classes and their implications for pharmacy benefit management.
  2. Identify key factors employers and purchasers consider when assessing coverage and reimbursement for high-investment drugs.
  3. Explain trends in services and offerings in the high-impact drug class space.
  4. Discuss strategies used by employers and payers in optimizing solutions and outcomes for high-impact drug classes.